Chlamydia Screening for Women
Compare Versions of: "Chlamydia Screening for Women"
The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.
Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.
Compare version to
| Measure Information | 2022 Performance Period | 2023 Performance Period | 2024 Performance Period | 2025 Performance Period |
|---|---|---|---|---|
| Title | Chlamydia Screening for Women | Chlamydia Screening in Women | Chlamydia Screening in Women | Chlamydia Screening in Women |
| CMS eCQM ID | CMS153v10 | CMS153v11 | CMS153v12 | CMS153v13 |
| CBE ID* | Not Applicable | Not Applicable | Not Applicable | Not Applicable |
| MIPS Quality ID | 310 | 310 | 310 | 310 |
| Measure Steward | National Committee for Quality Assurance | National Committee for Quality Assurance | National Committee for Quality Assurance | National Committee for Quality Assurance |
| Description |
Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period |
Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period |
Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during the measurement period |
Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during the measurement period |
| Measure Scoring | Proportion measure | Proportion measure | Proportion measure | Proportion measure |
| Measure Type | Process | Process | Process | Process |
| Stratification | *See CMS153v10.html | *See CMS153v11.html |
Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period Stratum 2: Patients age 21-24 by the end of the measurement period |
Report a total score, and each of the following strata: Stratum 1: Patients age 16-20 by the end of the measurement period. Stratum 2: Patients age 21-24 by the end of the measurement period. |
| Risk Adjustment | *See CMS153v10.html | *See CMS153v11.html |
None |
None |
| Rationale | *See CMS153v10.html | *See CMS153v11.html |
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in roughly 1.7 million cases (Centers for Disease Control and Prevention, 2019). Chlamydia infections are often asymptomatic, but, if left untreated, can lead to serious and irreversible complications (U.S. Preventive Services Task Force, 2014; Centers for Disease Control and Prevention, 2019). Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), which can lead to chronic pelvic pain or infertility. Pregnant women may also transmit the infection to their infant, potentially resulting in neonatal pneumonia (Centers for Disease Control and Prevention, 2019). |
Chlamydia trachomatis is the most common sexually transmitted bacterial infection in the U.S., resulting in roughly 1.7 million cases (Centers for Disease Control and Prevention, 2019). Chlamydia infections are often asymptomatic, but, if left untreated, can lead to serious and irreversible complications (U.S. Preventive Services Task Force, 2021; Centers for Disease Control and Prevention, 2019). Women are particularly vulnerable when infected with chlamydia. Left untreated, chlamydia can cause pelvic inflammatory disease (PID), which can lead to chronic pelvic pain or infertility. Pregnant women may also transmit the infection to their infant, potentially resulting in neonatal pneumonia (Centers for Disease Control and Prevention, 2019). |
| Clinical Recommendation Statement | *See CMS153v10.html | *See CMS153v11.html |
U.S. Preventive Services Task Force (2021) recommends screening for chlamydia in all sexually active women aged 24 years or younger and in women 25 years or older who are at increased risk for infection (B recommendation) |
U.S. Preventive Services Task Force (2021) recommends screening for chlamydia in all sexually active women aged 24 years or younger and in women 25 years or older who are at increased risk for infection (B recommendation) |
| Improvement Notation |
Higher score indicates better quality |
Higher score indicates better quality |
Higher score indicates better quality |
Higher score indicates better quality |
| Definition | *See CMS153v10.html | *See CMS153v11.html |
None |
None |
| Guidance |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. Patient self-report for procedures as well as diagnostic studies should be recorded in 'Procedure, Performed' template or 'Diagnostic Study, Performed' template in QRDA-1. Patient self-report is not allowed for laboratory tests. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center for more information on the QDM. |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
Codes to identify sexually active women include codes for: pregnancy, sexually transmitted infections, contraceptives or contraceptive devices, and infertility treatments. The denominator exclusion does not apply to patients who qualify for the initial population (IP) based on services other than the pregnancy test alone. These other services include services for sexually transmitted infections, contraceptives or contraceptive devices and infertility treatments. For example, a patient who has both a pregnancy test and a chlamydia diagnosis, either of which would qualify them for the IP, would not be eligible for this denominator exclusion. This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. |
| Initial Population |
Women 16 to 24 years of age who are sexually active and who had a visit in the measurement period |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
Women 16 to 24 years of age by the end of the measurement period who are sexually active and who had a visit in the measurement period |
| Denominator |
Equals Initial Population |
Equals Initial Population |
Equals Initial Population |
Equals Initial Population |
| Denominator Exclusions |
Women who are only eligible for the initial population due to a pregnancy test and who had an order for an x-ray or for a specified medication within 7 days of the pregnancy test. Exclude patients who are in hospice care for any part of the measurement period. |
Women who are only eligible for the initial population due to a pregnancy test and who had an order for an x-ray or for a specified medication within 7 days of the pregnancy test. Exclude patients who are in hospice care for any part of the measurement period. |
Women who are only eligible for the initial population due to a pregnancy test during the measurement period, and who had an order for an x-ray or for a specified medication on the date of the pregnancy test or the six days after the pregnancy test. Exclude patients who are in hospice care for any part of the measurement period. |
Exclude patients who are in hospice care for any part of the measurement period. Women who are only eligible for the initial population due to a pregnancy test during the measurement period, and who had an order for an x-ray or for a specified medication on the date of the pregnancy test or the six days after the pregnancy test. |
| Numerator |
Women with at least one chlamydia test during the measurement period |
Women with at least one chlamydia test during the measurement period |
Women with at least one chlamydia test during the measurement period |
Women with at least one chlamydia test during the measurement period |
| Numerator Exclusions |
Not Applicable |
Not Applicable |
Not Applicable |
Not Applicable |
| Denominator Exceptions |
None |
None |
None |
None |
| Telehealth Eligible | Yes | Yes | Yes | Yes |
| Next Version | No Version Available | |||
| Previous Version | No Version Available |
Additional Resources for CMS153v10
Header
Updated the eCQM version number.
Measure Section: eCQM Version Number
Source of Change: Annual Update
Updated copyright.
Measure Section: Copyright
Source of Change: Annual Update
Updated the rationale to align with current evidence.
Measure Section: Rationale
Source of Change: Measure Lead
Updated the clinical recommendation statement to align with current clinical recommendations.
Measure Section: Clinical Recommendation Statement
Source of Change: Measure Lead
Revised the denominator exclusions language to reduce ambiguity in the exclusions.
Measure Section: Denominator Exclusions
Source of Change: Measure Lead
Replaced 'overlaps' or 'overlapping' in the denominator exclusions with plain language to clarify the measure intent.
Measure Section: Denominator Exclusions
Source of Change: Measure Lead
Logic
Added online assessments and telephone visits as appropriate encounters based on the increased use of telehealth services.
Measure Section: Initial Population
Source of Change: Measure Lead
Revised the Diagnoses Identifying Sexual Activity definition to improve readability and simplify the logic.
Measure Section: Definitions
Source of Change: Measure Lead
Revised value set names to eliminate hyphens and align with style guide recommendations.
Measure Section: Definitions
Source of Change: Measure Lead
Updated the version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-6.2.000). Updated the 'Inpatient Encounter' definition to include a 'day of' timing clarification. Added the following timing functions: Normalize Interval, Has Start, Has End, Latest, Latest Of, Earliest, and Earliest Of. Please see individual measure details for application of specific timing functions.
Measure Section: Multiple Sections
Source of Change: Standards Update
Added new NormalizeInterval function to timing attributes to decrease implementation burden due to variable use of timing attributes for select QDM data types. The NormalizeInterval function was applied, where applicable, for the following data elements: Assessment, Performed; Device, Applied; Diagnostic Study, Performed; Intervention, Performed; Laboratory Test, Performed; Medication, Administered; Medication, Dispensed; Physical Exam, Performed; Procedure, Performed; Substance, Administered.
Measure Section: Multiple Sections
Source of Change: Standards Update
Updated Hospice CQL Library to version 3.0.000.
Measure Section: Multiple Sections
Source of Change: Measure Lead
Value Set
The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.
Value set Lab Tests for Sexually Transmitted Infections (2.16.840.1.113883.3.464.1003.110.12.1051): Added 61 LOINC codes, Deleted 4 LOINC codes (21416-3, 53605-2, 660-1, 73752-8) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.
Measure Section: Terminology
Source of Change: Measure Lead
Value set Chlamydia Screening (2.16.840.1.113883.3.464.1003.110.12.1052): Added 1 LOINC code (91860-7) based on terminology update.
Measure Section: Terminology
Source of Change: Annual Update
Value set Lab Tests During Pregnancy (2.16.840.1.113883.3.464.1003.111.12.1007): Added 6 LOINC codes (41067-0, 41096-9, 48802-3, 83072-9, 83073-7, 83075-2) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations. Deleted 11 LOINC codes (33773-3, 34656-9, 34718-7, 45273-0, 45331-6, 45332-4, 64088-8, 64094-6, 42316-0, 46731-6, 48030-1) based on updated evidence in published guidelines, published literature, or from published specialty medical society or group recommendations.
Measure Section: Terminology
Source of Change: Measure Lead
Value set Diagnostic Studies During Pregnancy (2.16.840.1.113883.3.464.1003.111.12.1008): Added 7 LOINC codes (11776-2, 11869-5, 42138-8, 42453-1, 76514-9, 80414-6, 80416-1) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Procedures During Pregnancy (2.16.840.1.113883.3.464.1003.111.12.1009) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Value set Pregnancy Test (2.16.840.1.113883.3.464.1003.111.12.1011): Added 2 LOINC codes (80385-8, 93769-8) based on terminology update.
Measure Section: Terminology
Source of Change: Annual Update
Removed value set Delivery Live Births (2.16.840.1.113883.3.464.1003.111.12.1015) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Gonococcal Infections and Venereal Diseases (2.16.840.1.113883.3.464.1003.112.12.1001) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Value set Complications of Pregnancy, Childbirth and the Puerperium (2.16.840.1.113883.3.464.1003.111.12.1012): Added 10 ICD-10-CM codes (O30.131, O30.132, O30.133, O30.139, O34.218, O34.22, O86.0, O99.891, O99.892, O99.893) based on review by technical experts, SMEs, and/or public feedback. Deleted 16 ICD-10-CM codes based on terminology update. Added 1627 SNOMED CT codes based on review by technical experts, SMEs, and/or public feedback. Deleted 52 SNOMED CT codes based on terminology update.
Measure Section: Terminology
Source of Change: Measure Lead
Value set Contraceptive Medications (2.16.840.1.113883.3.464.1003.196.12.1080): Added 2 RxNorm codes (2396242, 2396253). Deleted 3 RxNorm codes (105510, 198043, 749856) based on terminology update.
Measure Section: Terminology
Source of Change: Annual Update
Removed value set Genital Herpes (2.16.840.1.113883.3.464.1003.110.12.1049) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Other Female Reproductive Conditions (2.16.840.1.113883.3.464.1003.111.12.1006 based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Chlamydia (2.16.840.1.113883.3.464.1003.112.12.1003) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Inflammatory Diseases of Female Reproductive Organs (2.16.840.1.113883.3.464.1003.112.12.1004) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Value set X-Ray Study (all inclusive) (2.16.840.1.113883.3.464.1003.198.12.1034): Added 186 LOINC codes based on terminology update. Deleted 2125 LOINC codes based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Value set HIV (2.16.840.1.113883.3.464.1003.120.12.1003): Added 9 SNOMED CT codes (10755671000119100, 15928141000119107, 72631000119101, 771119002, 771126002, 771127006, 838377003, 840442003, 840498003) based on terminology update.
Measure Section: Terminology
Source of Change: Annual Update
Added value set Diagnoses used to Indicate Sexual Activity (2.16.840.1.113883.3.464.1003.111.12.1018) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Added value set Procedures used to Indicate Sexual Activity (2.16.840.1.113883.3.464.1003.111.12.1017) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Added value set Telephone Visits (2.16.840.1.113883.3.464.1003.101.12.1080) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Added value set Online Assessment (2.16.840.1.113883.3.464.1003.101.12.1089) based on change in measure requirements/measure specification.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Syphilis (2.16.840.1.113883.3.464.1003.112.12.1002) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead
Removed value set Carrier of Predominantly Sexually Transmitted Infection (2.16.840.1.113883.3.464.1003.112.11.1023) based on review by technical experts, SMEs, and/or public feedback.
Measure Section: Terminology
Source of Change: Measure Lead